Compound Detail
CHEMBL2107024
REVOSPIRONE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL2107024 |
| Name | REVOSPIRONE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | MPLTZRTXQLNGED-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
9
Publications
2
Known Names
Molecular Properties
387.5
MW (Da)
0.83
ALogP
7
HBA
0
HBD
86.7
PSA (Ų)
0.75
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Activity Summary
Ki 1 meas. best 8.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 8.7 | 8.7 | 2.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 1A | Ki | = | 2.0 | nM | 8.7 | Displacement of [3H]-5-OH-DPAT from human 5-HT1AR expressed in human HEK293 cell... | 33839253 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33839253 | 10.1016/j.bmcl.2021.128028 | 5-hydroxytryptamine receptor 1A | 1 |
| 33839253 | 10.1016/j.bmcl.2021.128028 | Adrenergic receptor alpha-1 | 1 |
| 33839253 | 10.1016/j.bmcl.2021.128028 | D(2) dopamine receptor | 1 |
| 33839253 | 10.1016/j.bmcl.2021.128028 | D(3) dopamine receptor | 1 |
| 33839253 | 10.1016/j.bmcl.2021.128028 | D(4) dopamine receptor | 1 |
| 33839253 | 10.1016/j.bmcl.2021.128028 | D(1B) dopamine receptor | 1 |
| 33839253 | 10.1016/j.bmcl.2021.128028 | 5-hydroxytryptamine receptor 2A | 1 |
| 33839253 | 10.1016/j.bmcl.2021.128028 | 5-hydroxytryptamine receptor 2C | 1 |
| 33839253 | 10.1016/j.bmcl.2021.128028 | D(1A) dopamine receptor | 1 |
Data from ChEMBL 36 via Core Engine